Case number 2017-1645
Mylan Institutional LLC v. Aurobindo Pharma Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | MYLAN INSTITUTIONAL LLC v. AUROBINDO PHARMA LTD. [OPINION] [precedential] (0) |
| Jul 27, 2017 | 97 | Mandate issued to the United States District Court for the Eastern District of Texas. Service as of this date by Clerk of Court. [449625] [JAB] [Entered: 07/27/2017 09:51 AM] (1) |
| Jul 20, 2017 | 96 | ORDER filed denying [94] petition for panel rehearing filed by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC; denying [94] petition for en banc rehearing filed by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [447885] [SJ] [Entered: 07/20/2017 10:57 AM] (2) |
| Jun 20, 2017 | 95 | 18 paper copies of the petition for panel rehearing [94], petition for en banc rehearing [94] received from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. [441042] [SJ] [Entered: 06/21/2017 11:33 AM] (0) |
| Jun 19, 2017 | 94 | Petition for panel rehearing, for en banc rehearing filed by Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 06/19/2017 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 06/21/2017 [440352] [Sailesh Patel] [Entered: 06/19/2017 01:14 PM] (51) |
| May 19, 2017 | 93 | Entry of appearance for Anna G. Phillips as of counsel for Appellee Mylan Institutional LLC. Service: 05/19/2017 by email. [432803] [Anna Phillips] [Entered: 05/19/2017 12:06 PM] (1) |
| May 19, 2017 | 92 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Lourie,Circuit Judge; Moore,Circuit Judge and Reyna,Circuit Judge). [432704] [SJ] [Entered: 05/19/2017 09:41 AM] (28) |
| May 15, 2017 | 91 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [431545] [CAB] [Entered: 05/15/2017 04:06 PM] (0) |
| Apr 10, 2017 | 90 | Submitted after ORAL ARGUMENT by Sailesh K. Patel for Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC and Nicole W. Stafford for Mylan Institutional LLC and Apicore US LLC. Panel: Judge: Lourie , Judge: Moore , Judge: Reyna. [422669] [JAB] [Entered: 04/10/2017 10:08 AM] (0) |
| Apr 7, 2017 | 89 | Second Amended Notice of Appeal for Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., and AuroMedics Pharma LLC. Service: 04/05/2017 by email. [422349] [JCA] [Entered: 04/07/2017 12:10 PM] (90) |
| Apr 5, 2017 | 88 | Amended Notice of Appeal for Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., and AuroMedics Pharma LLC. Service: 04/05/2017 by email. [421858] [Sailesh Patel] [Entered: 04/05/2017 06:52 PM] (7) |
| Apr 5, 2017 | 87 | AMENDED Response to oral argument order from the Appellees Apicore US LLC and Mylan Institutional LLC. designating Nicole W. Stafford as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [421669] [Nicole Stafford] [Entered: 04/05/2017 12:43 PM] (0) |
| Mar 29, 2017 | 86 | BRIEF FILED (CD-ROM) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. Number of Copies: 6. [420201] [CAB] [Entered: 03/30/2017 10:58 AM] (0) |
| Mar 29, 2017 | 85 | 6 paper copies of the Confidentila Joint Appendix [83] received from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [419959] [CAB] [Entered: 03/29/2017 01:59 PM] (0) |
| Mar 29, 2017 | 84 | JOINT APPENDIX FILED for AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [81]. Number of Pages: 678. Service: 03/29/2017 by email. [419957] [CAB] [Entered: 03/29/2017 01:57 PM] (678) |
| Mar 29, 2017 | 83 | CONFIDENTIAL JOINT APPENDIX, VOL. I - III FILED for AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [82]. Number of Pages: 1,296. Service: 03/29/2017 by email. [419949] [CAB] [Entered: 03/29/2017 01:48 PM] (0) |
| Mar 29, 2017 | 82 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 03/29/2017 by email. [419861] [Sailesh Patel] [Entered: 03/29/2017 11:53 AM] (0) |
| Mar 29, 2017 | 81 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: JOINT APPENDIX. Service: 03/29/2017 by email. [419855] [Sailesh Patel] [Entered: 03/29/2017 11:48 AM] (678) |
| Mar 28, 2017 | 80 | 6 paper copies of the Reply Brief [78] received from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [419640] [CAB] [Entered: 03/28/2017 03:22 PM] (0) |
| Mar 27, 2017 | 79 | REPLY BRIEF FILED for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [76]. Number of Pages: 29. Service: 03/27/2017 by email. Joint Appendix is due no later than 03/29/2017; paper copies of the Joint Appendix should be filed contemporaneously with the electronic filing. [419418] [CAB] [Entered: 03/28/2017 10:13 AM] (41) |
| Mar 27, 2017 | 78 | CONFIDENTIAL REPLY BRIEF FILED for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [77]. Number of Pages: 29. Service: 03/27/2017 by email. The paper copies of the brief are supposed to be filed contemporaneously with the electronic filing (see 03/10/2017 Order, Doc #45). [419410] [CAB] [Entered: 03/28/2017 10:00 AM] (0) |
| Mar 27, 2017 | 77 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CONFIDENTIAL REPLY BRIEF Service: 03/27/2017 by email. [419352] [Sailesh Patel] [Entered: 03/27/2017 10:54 PM] (0) |
| Mar 27, 2017 | 76 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: REPLY BRIEF. Service: 03/27/2017 by email. [419351] [Sailesh Patel] [Entered: 03/27/2017 10:49 PM] (41) |
| Mar 24, 2017 | 75 | Amended Entry of appearance for Allen F. Gardner as of counsel for Appellee Apicore US LLC. Service: 03/24/2017 by email. [418760] [Allen Gardner] [Entered: 03/24/2017 01:36 PM] (2) |
| Mar 24, 2017 | 74 | CORRECTED certificate of service for attorney entry of appearance , Doc No. [72]. Service: 03/24/2017 by email. [418730] [Joanna Goldstein] [Entered: 03/24/2017 01:00 PM] (1) |
| Mar 24, 2017 | 73 | NOTICE OF DEFICIENCY: The attorney entry of appearance for Attorney Joanna Garelick Goldstein, Document No. [72] filed by Appellee Apicore US LLC in 17-1645 is indicating more than one principal attorney for the party(s) and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [418684] [CAB] [Entered: 03/24/2017 11:37 AM] (0) |
| Mar 24, 2017 | 72 | Entry of appearance for Joanna Garelick Goldstein, Esq. as principal counsel for Appellee Apicore US LLC. Service: 03/24/2017 by email. [418661] [Joanna Goldstein] [Entered: 03/24/2017 11:04 AM] (1) |
| Mar 21, 2017 | 71 | Entry of appearance for Sami Sedghani as of counsel for Appellee Mylan Institutional LLC. Service: 03/21/2017 by email. [417670] [Sami Sedghani] [Entered: 03/21/2017 06:09 PM] (3) |
| Mar 20, 2017 | 70 | 6 paper copies of the Opening Response Brief [68] received from Appellees Apicore US LLC and Mylan Institutional LLC. [417276] [CAB] [Entered: 03/21/2017 09:49 AM] (0) |
| Mar 20, 2017 | 69 | BRIEF FILED for Appellees Apicore US LLC and Mylan Institutional LLC [66]. Number of Pages: 56. Service: 03/20/2017 by email. Appellants’ reply brief is due no later than 03/27/2017. [417275] [CAB] [Entered: 03/21/2017 09:47 AM] (71) |
| Mar 20, 2017 | 68 | CONFIDENTIAL BRIEF FILED for Appellees Apicore US LLC and Mylan Institutional LLC [67]. Number of Pages: 56. Service: 03/20/2017 by US mail, email. [417271] [CAB] [Entered: 03/21/2017 09:40 AM] (0) |
| Mar 20, 2017 | 67 | TENDERED from Appellees Apicore US LLC and Mylan Institutional LLC. Title: CONFIDENTIAL RESPONSE BRIEF Service: 03/20/2017 by email. [417109] [Nicole Stafford] [Entered: 03/20/2017 04:23 PM] (0) |
| Mar 20, 2017 | 66 | TENDERED from Appellees Apicore US LLC and Mylan Institutional LLC. Title: RESPONSE BRIEF. Service: 03/20/2017 by email. [417105] [Nicole Stafford] [Entered: 03/20/2017 04:21 PM] (71) |
| Mar 17, 2017 | 65 | 6 paper copies of the Second Corrected Opening Brief [53] received from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [416556] [CAB] [Entered: 03/17/2017 11:53 AM] (0) |
| Mar 17, 2017 | 64 | CORRECTED Response to oral argument order from the Appellees Apicore US LLC and Mylan Institutional LLC. designating David S. Steuer as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [416500] [David Steuer] [Entered: 03/17/2017 09:34 AM] (0) |
| Mar 17, 2017 | 63 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [62], calendar response Docket No. [61], ERROR: All appellees must share argument time. Total time indicated on the responses to oral argument order for all appellees exceeds the 15 minutes of argument time allotted per side. CORRECTION: Please submit corrected responses indicating how the 15 minutes of argument time will be divided among all appellees by midnight on the date of this notice. [416447] [JAB] [Entered: 03/17/2017 08:35 AM] (0) |
| Mar 16, 2017 | 62 | Response to oral argument order from the Appellee Apicore US LLC. designating David Steuer as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [416403] [Allen Gardner] [Entered: 03/16/2017 05:20 PM] (0) |
| Mar 16, 2017 | 61 | Response to oral argument order from the Appellee Mylan Institutional LLC. designating David S. Steuer as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [416353] [David Steuer] [Entered: 03/16/2017 04:23 PM] (0) |
| Mar 16, 2017 | 60 | Response to oral argument order from the Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. designating Sailesh K. Patel as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [416243] [George Yu] [Entered: 03/16/2017 02:10 PM] (0) |
| Mar 16, 2017 | 59 | Notice to counsel for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. and Appellees Apicore US LLC and Mylan Institutional LLC: The record of this case indicates that the Responses to Oral Argument Order have not been filed. The responses were due on or before 3/15/2017. Counsel should promptly docket the Response to Oral Argument Order event and designate which attorneys will present argument for the parties. Service as of this date by Clerk of Court. [416197] [JAB] [Entered: 03/16/2017 01:05 PM] (0) |
| Mar 15, 2017 | 58 | Sealed or confidential document received [Corrected Confidential Opposition to Motion to Expedite Appeal] (corresponding to Doc No. [57]) for Appellees Apicore US LLC and Mylan Institutional LLC. Service: 03/15/2017 by email. [415926] [David Steuer] [Entered: 03/15/2017 06:03 PM] (0) |
| Mar 15, 2017 | 57 | RESPONSE of Appellees Apicore US LLC and Mylan Institutional LLC to the motion to expedite appeal [7] filed by Appellants Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC in 17-1645. Service: 03/15/2017 by email. [415924] [David Steuer] [Entered: 03/15/2017 06:00 PM] (32) |
| Mar 15, 2017 | 56 | Sealed or confidential document received [Corrected Appellees' Opposition to Appellants' Emergency Motion for Stay of Preliminary Injuction Pending Appeal] (corresponding to Doc No. [55]) for Appellees Apicore US LLC and Mylan Institutional LLC. Service: 03/15/2017 by email. [415923] [David Steuer] [Entered: 03/15/2017 05:57 PM] (0) |
| Mar 15, 2017 | 55 | RESPONSE of Appellees Apicore US LLC and Mylan Institutional LLC to the motion for emergency stay pending appeal [9] filed by Appellants Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC in 17-1645. Service: 03/15/2017 by email. [415917] [David Steuer] [Entered: 03/15/2017 05:50 PM] (81) |
| Mar 14, 2017 | 52 | CORRECTED certificate of service for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. for confidential Brief , Doc No. [49]. Service: 03/14/2017 by email. [415241] [Sailesh Patel] [Entered: 03/14/2017 11:46 AM] (1) |
| Mar 14, 2017 | 51 | CORRECTED certificate of service for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. for Brief , Doc No. [48]. Service: 03/14/2017 by email. [415238] [Sailesh Patel] [Entered: 03/14/2017 11:44 AM] (1) |
| Mar 14, 2017 | 50 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:confidential Brief Docket No. [49], Brief Docket No. [48], ERROR: Appellants' 2nd Corrected Confidential and Non-Confidential Opening Brief does not have a proper/complete Certificate of Service. CORRECTION: Please promptly file a Corrected Certificate of Service for the briefs, and relate to the tendered briefs (Doc Nos. 48 and 49). [415170] [CAB] [Entered: 03/14/2017 09:47 AM] (0) |
| Mar 13, 2017 | 49 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 03/13/2017 by email. [415095] [Sailesh Patel] [Entered: 03/13/2017 06:43 PM] (0) |
| Mar 13, 2017 | 53 | SECOND CORRECTED CONFIDENTIAL BRIEF FILED for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [49]. Number of Pages: 62. Service: 03/13/2017 by email. [415306] [CAB] [Entered: 03/14/2017 01:34 PM] (0) |
| Mar 13, 2017 | 54 | SECOND CORRECTED BRIEF FILED for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [48]. Number of Pages: 62. Service: 03/13/2017 by email. Appellees’ response brief is due no later than 03/20/2017. [415311] [CAB] [Entered: 03/14/2017 01:41 PM] (82) |
| Mar 13, 2017 | 48 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CORRECTED OPENING BRIEF. Service: 03/13/2017 by email. [415094] [Sailesh Patel] [Entered: 03/13/2017 06:41 PM] (81) |
| Mar 13, 2017 | 47 | Notice of Correction to the confidential Brief Doc No. [40], Brief Doc No. [39] for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/13/2017 by email. [415091] [Sailesh Patel] [Entered: 03/13/2017 06:38 PM] (5) |
| Mar 10, 2017 | 46 | NOTICE OF CALENDARING. Panel: 1704R. Case scheduled Apr 10, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 03/15/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [414438] [JAB] [Entered: 03/10/2017 01:51 PM] (0) |
| Mar 10, 2017 | 45 | ORDER filed denying [9] motion for emergency stay pending appeal filed by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC, denying [42] motion for emergency stay pending appeal filed by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC; The appellees are directed to file paper versions of their brief contemporaneously with their filing of the electronic version of the brief. The appellants are directed to file paper versions of the reply brief and joint appendix contemporaneously with the electronic filing of those documents.; Oral argument on the merits will be held on April 10, 2017 at 10:00 a.m. (Per Curiam). Service: 03/10/2017 by clerk. [414385] [NL] [Entered: 03/10/2017 01:08 PM] (2) |
| Mar 10, 2017 | 43 | Sealed or confidential document received [Appellants' Corrected Confidential Emergency Motion to Stay Pending Appeal] (corresponding to Doc No. [42]) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/10/2017 by email. [414363] [George Yu] [Entered: 03/10/2017 12:19 PM] (0) |
| Mar 10, 2017 | 42 | MOTION of Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. for an emergency stay pending appeal under Rule 8 [Consent: opposed]. Service: 03/10/2017 by email. [414361] [George Yu] [Entered: 03/10/2017 12:16 PM] (227) |
| Mar 10, 2017 | 41 | Certificate of Compliance with the Confidentialtiy Requirement of Fed. Cir. R. 27(m) (Motion/Response/Reply) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/10/2017 by email. [414356] [George Yu] [Entered: 03/10/2017 12:13 PM] (1) |
| Mar 10, 2017 | 40 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 03/10/2017 by email. [414354] [George Yu] [Entered: 03/10/2017 12:12 PM] (0) |
| Mar 10, 2017 | 39 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CORRECTED OPENING BRIEF. Service: 03/10/2017 by email. [414351] [George Yu] [Entered: 03/10/2017 12:10 PM] (0) |
| Mar 10, 2017 | 38 | Certificate of Compliance with the Confidentialtiy Requirement of Fed. Cir. R. 28(d) (Briefs) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/10/2017 by email. [414348] [George Yu] [Entered: 03/10/2017 12:08 PM] (1) |
| Mar 10, 2017 | 37 | Notice of Correction to the confidential Brief Doc No. [32], Brief Doc No. [30] for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/10/2017 by email. [414347] [George Yu] [Entered: 03/10/2017 12:07 PM] (5) |
| Mar 9, 2017 | 36 | Sealed or confidential document received [CONFIDENTIAL Reply Brief in Support of Appellants' Emergency Motion to Stay] (corresponding to Doc No. [35]) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/09/2017 by email. [414136] [George Yu] [Entered: 03/09/2017 04:55 PM] (0) |
| Mar 9, 2017 | 35 | REPLY of Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to response filed by Appellees in 17-1645 , Doc. No [26]. Service: 03/09/2017 by email. [414135] [George Yu] [Entered: 03/09/2017 04:52 PM] (31) |
| Mar 8, 2017 | 34 | ORDER filed. The motions to file under sean [11] [22] [29] [33] are denied. The documents previously offered under seal will remain confidential and thus not viewable by the public. Within 7 days of the date of this order, the appellants are directed to file corrected confidential and nonconfidential versions of their motion to stay and their opening brief, in conformance with the discussion in the order. Within 7 days of the date of this order, the appellees are directed to file corrected confidential and nonconfidential versions of their response to the motion to stay and their response to the motion to expedite, in conformance with the discussion in the order. Future documents should also comply with the requirements noted in the order. (Per Curiam). Service: 03/08/2017 by clerk. [413353] [LMS] [Entered: 03/08/2017 11:56 AM] (3) |
| Mar 6, 2017 | 33 | MOTION of Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to seal document confidential Brief [32]. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/06/2017 by email. [412858] [Sailesh Patel] [Entered: 03/06/2017 06:03 PM] (21) |
| Mar 6, 2017 | 32 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: CONFIDENTIAL OPENING BRIEF Service: 03/06/2017 by email. [412857] [Sailesh Patel] [Entered: 03/06/2017 05:59 PM] (0) |
| Mar 6, 2017 | 31 | Certificate of Compliance with the Confidentialtiy Requirement of Fed. Cir. R. 28(d) (Briefs) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/06/2017 by email. [412856] [Sailesh Patel] [Entered: 03/06/2017 05:57 PM] (1) |
| Mar 6, 2017 | 30 | TENDERED from Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: OPENING BRIEF. Service: 03/06/2017 by email. [412855] [Sailesh Patel] [Entered: 03/06/2017 05:55 PM] (0) |
| Mar 6, 2017 | 29 | MOTION of Appellees Apicore US LLC and Mylan Institutional LLC to seal document confidential document [27]. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/06/2017 by email. [412846] [David Steuer] [Entered: 03/06/2017 05:13 PM] (14) |
| Mar 6, 2017 | 28 | Certificate of Compliance with the Confidentialtiy Requirement of Fed. Cir. R. 27(m) (Motion/Response/Reply) for Appellees Apicore US LLC and Mylan Institutional LLC. Service: 03/06/2017 by email. [412842] [David Steuer] [Entered: 03/06/2017 05:00 PM] (1) |
| Mar 6, 2017 | 27 | Sealed or confidential document received [Appellees Opposition to Appellants Emergency Motion For Stay Of Preliminary Injunction Pending Appeal] (corresponding to Doc No. [26]) for. Service: 03/06/2017 by email. [412841] This document has been corrected. See Doc No. 56. [David Steuer] [Entered: 03/06/2017 04:56 PM] (0) |
| Mar 6, 2017 | 26 | RESPONSE of Appellees Apicore US LLC and Mylan Institutional LLC to the motion for emergency stay pending appeal [9] filed by Appellants Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC in 17-1645. Service: 03/06/2017 by email. [412836] This document has been corrected. See Doc No. 55 [David Steuer] [Entered: 03/06/2017 04:49 PM] (0) |
| Mar 3, 2017 | 25 | Docketing Statement for the Appellee Apicore US LLC. Service: 03/03/2017 by email. [412567] [Allen Gardner] [Entered: 03/03/2017 09:32 PM] (4) |
| Mar 3, 2017 | 24 | Docketing Statement for the Appellee Mylan Institutional LLC. Service: 03/03/2017 by email. [412557] [David Steuer] [Entered: 03/03/2017 07:30 PM] (4) |
| Mar 3, 2017 | 23 | ORDER filed. The motion to expedite appeal [7] filed by Appellants Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC is granted to the extent that Appellants’ opening brief is due no later than March 6, 2017; Appellees’ response brief is due no later than March 20, 2017; Appellants’ reply brief is due no later than March 27, 2017; and the joint appendix is due no later than March 29, 2017. No extensions should be anticipated.; Oral argument will be scheduled by subsequent order of the court. (Per Curiam). Service: 03/03/2017 by clerk. [412540] [NL] [Entered: 03/03/2017 05:40 PM] (2) |
| Mar 3, 2017 | 22 | MOTION of Appellees Apicore US LLC and Mylan Institutional LLC to seal document confidential Brief [20]. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/03/2017 by email. [412520] [David Steuer] [Entered: 03/03/2017 04:54 PM] (12) |
| Mar 3, 2017 | 21 | Docketing Statement for the Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/03/2017 by email. [412518] [George Yu] [Entered: 03/03/2017 04:51 PM] (3) |
| Mar 3, 2017 | 20 | CORRECTED ENTRY: Sealed or confidential document received [Plaintiffs-Appellees' Response to Defendants-Appellants' Motion to Expedite Appeal] (corresponding to Doc No. [19]) for Appellees Apicore US LLC and Mylan Institutional LLC. Service: 03/03/2017 by email. [412517] --[Edited 03/06/2017 by CB - Reason: to correct event docketed] This document has been corrected. See Doc No. 58. [David Steuer] [Entered: 03/03/2017 04:49 PM] (0) |
| Mar 3, 2017 | 19 | RESPONSE of Appellees Apicore US LLC and Mylan Institutional LLC to the motion to expedite appeal [7] filed by Appellants Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC in 17-1645. Service: 03/03/2017 by email. [412515] This document has been corrected. See Doc No. 57. [David Steuer] [Entered: 03/03/2017 04:44 PM] (0) |
| Mar 3, 2017 | 18 | Certificate of Interest for the Appellee Apicore US LLC. Service: 03/03/2017 by email. [412495] [Allen Gardner] [Entered: 03/03/2017 04:12 PM] (4) |
| Mar 3, 2017 | 17 | Entry of appearance for Allen F. Gardner as principal counsel for Appellee Apicore US LLC. Service: 03/03/2017 by email. [412492] [Allen Gardner] [Entered: 03/03/2017 04:06 PM] (2) |
| Mar 3, 2017 | 16 | Entry of appearance for Nicole W. Stafford as of counsel for Appellee Mylan Institutional LLC. Service: 03/03/2017 by email. [412481] [Nicole Stafford] [Entered: 03/03/2017 03:58 PM] (2) |
| Mar 3, 2017 | 15 | Certificate of Interest for the Appellee Mylan Institutional LLC. Service: 03/03/2017 by email. [412455] [David Steuer] [Entered: 03/03/2017 03:22 PM] (4) |
| Mar 3, 2017 | 14 | Entry of appearance for David S. Steuer as principal counsel for Appellee Mylan Institutional LLC. Service: 03/03/2017 by email. [412398] [David Steuer] [Entered: 03/03/2017 02:20 PM] (2) |
| Mar 1, 2017 | 12 | ORDER filed. Appellees are directed to respond to the motion for a stay pending appeal [9] no later than 5 p.m. on March 6, 2017. Any reply in support of the motion is due no later than 5:00 p.m. on March 9, 2017. The request for an immediate stay is denied. (Per Curiam). Service: 03/01/2017 by clerk. [411757] [LMS] [Entered: 03/01/2017 04:23 PM] (2) |
| Feb 28, 2017 | 13 | Amended Docket Report and Amended Notice of Appeal for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. from the United States District Court for the Eastern District of Texas. Service: 03/03/2017 by clerk. [412289] [CAB] [Entered: 03/03/2017 11:12 AM] (81) |
| Feb 28, 2017 | 11 | MOTION of Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to seal document confidential document [10]. Any response is due within 10 days of service [Consent: opposed]. Service: 02/28/2017 by email. [411442] [George Yu] [Entered: 02/28/2017 07:56 PM] (23) |
| Feb 28, 2017 | 10 | Sealed or confidential document received [Emergency Motion for Stay of Preliminary Injunction Pending Appeal] (corresponding to Doc No. [9]) for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 02/28/2017 by email. [411441] [George Yu] [Entered: 02/28/2017 07:54 PM] (0) |
| Feb 28, 2017 | 9 | MOTION of Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. for an emergency stay pending appeal under Rule 8 [Consent: opposed]. Service: 02/28/2017 by email. [411440] [George Yu] [Entered: 02/28/2017 07:48 PM] (227) |
| Feb 28, 2017 | 8 | ORDER filed. Any opposition to the motion [7] is due no later than 5:00 p.m. on Friday, March 3, 2017. Any reply in support of the motion is due no later than 5:00 p.m. on Tuesday, March 7, 2017. Service: 02/28/2017 by clerk. [411106] [LMS] [Entered: 02/28/2017 10:38 AM] (2) |
| Feb 27, 2017 | 7 | MOTION of Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to expedite case. Any response is due within 10 days of service [Consent: opposed]. Service: 02/27/2017 by email. [411008] [George Yu] [Entered: 02/27/2017 06:40 PM] (71) |
| Feb 27, 2017 | 6 | Amended Notice of Appeal for Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., AuroMedics Pharma LLC. Service: 02/27/2017 by email. [411007] [George Yu] [Entered: 02/27/2017 06:37 PM] (6) |
| Feb 27, 2017 | 5 | Entry of appearance for Cindy Ahn as of counsel for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 02/27/2017 by email. [410983] [Cindy Ahn] [Entered: 02/27/2017 04:59 PM] (3) |
| Feb 23, 2017 | 4 | Entry of appearance for George C. Yu as of counsel for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 02/23/2017 by email. [410269] [George Yu] [Entered: 02/23/2017 07:45 PM] (3) |
| Feb 23, 2017 | 3 | Certificate of Interest for the Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 02/23/2017 by email. [410218] [Sailesh Patel] [Entered: 02/23/2017 04:48 PM] (4) |
| Feb 23, 2017 | 2 | Entry of appearance for Sailesh K. Patel as principal counsel for Appellants AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 02/23/2017 by email. [410216] [Sailesh Patel] [Entered: 02/23/2017 04:46 PM] (3) |
| Feb 17, 2017 | 1 | Appeal docketed. Received: 02/10/2017. [408611]Entry of Appearance due 03/03/2017. Certificate of Interest is due on 03/03/2017. Docketing Statement due 03/03/2017. Appellants' brief is due 04/18/2017. [CAB] [Entered: 02/17/2017 12:31 PM] (27) |
